देश: ताइवान
भाषा: चीनी
स्रोत: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Abiraterone Acetate
嬌生股份有限公司 台北市中山區民生東路三段2號10樓及11樓 (30814854)
L02BX03
膜衣錠
Abiraterone Acetate (9200093900) MG
塑膠瓶裝(HDPE)
製 劑
須由醫師處方使用
JANSSEN-CILAG S.P.A. VIA C. JANSSEN 04100 BORGO S. MICHELE-LATINA, ITALY IT
abiraterone
ZYTIGA® 是一種CYP17 抑制劑,與prednisone 或prednisolone 併用,以治療(1)藥物或手術去勢抗性的轉移性前列腺癌,且在雄性素去除療法失敗後屬無症狀或輕度症狀而尚未需要使用化學治療(chemotherapy is not yet clinically indicated)者。(2)藥物或手術去勢抗性的轉移性前列腺癌且已接受過docetaxel 治療者。(3)新診斷具高風險的荷爾蒙敏感性轉移性前列腺癌的成年男性,且與雄性素去除療法併用。
註銷日期: 2023/08/07; 註銷理由: 自請註銷; 有效日期: 2022/12/25; 英文品名: ZYTIGA® Film-Coated Tablets 250mg
已註銷
2017-12-25
® 250 ZYTIGA ® Film-Coated Tablets 250 mg 027356 | 1 | 1 ZYTIGA ® CYP17 prednisone prednisolone 1 chemotherapy is not yet clinically indicated 2 docetaxel 3 2 2.1 ZYTIGA ® 1,000 2 500 4 250 prednisone prednisolone 5 | 2 | ZYTIGA ® 1,000 2 500 4 250 prednisone prednisolone 5 ZYTIGA ® ZYTIGA ® 2 ZYTIGA ® 1 11.2 2.2 Child-Pugh Class B ZYTIGA ® 250 250 AUC 1,000 AUC | 3 | 250 ALT AST ALT AST ULN 5 3 ULN ZYTIGA ® ZYTIGA ® 8.511.2 Child-Pugh Class C ZYTIGA ® ZYTIGA ® ALT AST 5 ULN 3 ULN ZYTIGA ® 5.3 AST ALT 2.5 ULN 1.5 ULN 750 | 4 | 3 酶 750 AST ALT 2.5 ULN 1.5 ULN 500 5 0 0 ZYTIGA ® AST ALT 20 ULN 10 ULN ZYTIGA ® ALT 3 ULN total bilirubin 2 ULN ZYTIGA ® 5.3 | 5 | 2.3 CYP3A4 ZYTIGA ® CYP3A4 phenytoin carbamazepine rifampin rifabutin rifapentine phenobarbital CYP3A4 CYP3A4 ZYTIGA ® 1,000 1,000 CYP3A4 7.111.2 3 ZYTIGA ® abiraterone acetate 250 ZYTIGA ® abiraterone acetate 250 AA250 | 6 | 4 4.1 ZYTIGA ® ZYTIGA ® ZYTIGA ® 8.1 5 5.1 ZYTIGA ® CYP17 11.1 ZYTIGA ® 2% 3-4 4% 3-4 | 7 | 1% 3-4 6 ACTH ZYTIGA ® < 50%NYHA III IV 1 NYHA II IV 3011 2 ZYTIGA ® 13 ZYTIGA ® 5.2 0.5% ZYTIGA ® 0.2% | 8 | ZYTIGA ® prednisone prednisone prednisone ZYTIGA ® 5.1 5.3 ZYTIGA ® 6.2 ZYTIGA ® 4% 3 4 पूरा दस्तावेज़ पढ़ें